Arcturus Therapeutics Holdings (ARCT) Capital Expenditures (QoQ) (2018 - 2025)
Arcturus Therapeutics Holdings (ARCT) Capital Expenditures (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -148.62% |
| Sep 30, 2024 | -75.61% |
| Jun 30, 2024 | 36.67% |
| Mar 31, 2024 | -72.57% |
| Dec 31, 2023 | -39.61% |
| Sep 30, 2023 | 208.30% |
| Jun 30, 2023 | 339.25% |
| Mar 31, 2023 | 103.20% |
| Dec 31, 2022 | -253.06% |
| Sep 30, 2022 | 678.31% |
| Jun 30, 2022 | -117.91% |
| Mar 31, 2022 | 30,257.14% |
| Dec 31, 2021 | 98.48% |
| Sep 30, 2021 | -214.36% |
| Jun 30, 2021 | 242.37% |
| Mar 31, 2021 | 113.47% |
| Dec 31, 2020 | -187.51% |
| Sep 30, 2020 | 559.17% |
| Jun 30, 2020 | -183.21% |
| Mar 31, 2020 | 199.62% |